Iovance, A Top 1% Biotech Stock, Crashes In A Surprise Lung Cancer Twist
· investors.com · popularity 17/100 · 0 similar stories today · Cancer & Oncology (Health & Life Sciences)
Read the original at investors.com →
Summary
Iovance stock crashed Thursday, undercutting its 50-day line, on new durability questions on its experimental lung cancer treatment. Roughly a …
Found in: Investing. Rating basis: single outlet; outlet tier 2 (unlisted); 1 feeds; feed position 14.